Physician profile
Lon D Cartwright
NPI 1487723920
$1,687.63
in general payments reported to CMS, 2019-2025
11 companies · $20.36 in 2025
The $20.36 reported for 2025 was less than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12.51 · 2020: $116 · 2022: $564 · 2023: $484 · 2024: $491 · 2025: $20.36.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $825 · Entertainment: $170.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $825.02 |
| Entertainment | $170.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Vision Care, INC. | $562.54 | 2019-2025 | Acuvue |
| Bausch & Lomb Americas INC. | $243.12 | 2022-2024 | Miebo |
| Optos, INC. | $170.42 | 2023-2024 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Lkc Technologies, INC. | $119.21 | 2023 | |
| Sun Pharmaceutical Industries INC. | $118.18 | 2024 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $115.74 | 2020 | |
| Tarsus Pharmaceuticals, INC. | $94.25 | 2024 | Xdemvy |
| Coopervision INC. | $90.53 | 2023 | Myday Contact Lens |
| Alcon Vision LLC | $69.36 | 2022 | |
| Carl Zeiss Meditec USA, INC. | $55.54 | 2024 | Cirrus Hd-Oct |
| Genzyme Corporation | $48.74 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lon Cartwright listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.